Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2862775 | American Journal of Hypertension | 2007 | 5 Pages |
Abstract
This study shows for the first time that in an animal model of MS, the insulin sensitizer, rosiglitazone, improves the metabolic profile and increases plasma levels of adiponectin and its gene expression. It is possible therefore that rosiglitazone exerts its beneficial effects by increasing the levels of adiponectin.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Yehonatan Sharabi, Mor Oron-Herman, Yehuda Kamari, Irit Avni, Edna Peleg, Zehava Shabtay, Ehud Grossman, Arie Shamiss,